Patent · US Active

THRB receptor agonist compound and preparation method and use thereof

US11034676B2 · kind B2 · utility

5Cited by

3References

29Claims

0Family size

Assignee

Terns, Inc. · US

Inventors

Shanghai Yu · Shanghai, CN
Ben Li · Po Tong Ha, CN

Key dates

Filing date	Sep 4, 2020
Grant date	Jun 15, 2021
Priority date	—
Expiry date	Sep 4, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention discloses a compound represented by the following Formula (I) and a pharmaceutically acceptable salt thereof. The compound improves the THRα selectivity while maintaining good THRβ agonistic activity, thereby improving properties of the finished drug.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.